Nifty
Sensex
:
:
24330.95
77958.52
298.15 (1.24%)
940.73 (1.22%)

Agriculture

Rating :
52/99

BSE: 537291 | NSE: NATHBIOGEN

177.12
06-May-2026
  • Open
  • High
  • Low
  • Previous Close
  •  179.4
  •  179.8
  •  173.18
  •  173.11
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  64871
  •  11485542.53
  •  238.69
  •  126.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 334.47
  • 8.03
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 396.98
  • 1.14%
  • 0.49

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 45.60%
  • 14.70%
  • 34.40%
  • FII
  • DII
  • Others
  • 0.22%
  • 0.01%
  • 5.07%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.37
  • 3.33
  • 6.59

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.84
  • -4.73
  • 0.40

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.51
  • -5.41
  • 3.31

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.06
  • 10.96
  • 9.23

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.21
  • 0.33
  • 0.54

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.43
  • 13.98
  • 8.26

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
51.59
51.97
-0.73%
65.96
36.87
78.90%
43.85
32.19
36.22%
283.70
243.88
16.33%
Expenses
47.11
51.55
-8.61%
62.39
28.84
116.33%
37.75
27.38
37.87%
245.42
207.34
18.37%
EBITDA
4.48
0.41
992.68%
3.57
8.04
-55.60%
6.10
4.81
26.82%
38.28
36.53
4.79%
EBIDTM
8.68%
0.79%
5.42%
21.80%
13.92%
14.95%
13.49%
14.98%
Other Income
2.38
3.86
-38.34%
1.74
0.48
262.50%
1.94
0.08
2,325.00%
1.76
0.13
1,253.85%
Interest
4.59
1.37
235.04%
4.54
3.90
16.41%
3.66
2.98
22.82%
3.20
2.24
42.86%
Depreciation
1.03
1.34
-23.13%
0.98
0.83
18.07%
0.99
0.83
19.28%
0.98
0.83
18.07%
PBT
2.49
1.57
58.60%
2.48
3.79
-34.56%
3.39
1.09
211.01%
35.88
33.60
6.79%
Tax
2.50
0.63
296.83%
0.87
1.14
-23.68%
0.64
-0.03
-
0.66
0.25
164.00%
PAT
-0.01
0.94
-
1.61
2.65
-39.25%
2.75
1.11
147.75%
35.22
33.35
5.61%
PATM
-0.02%
1.81%
2.43%
7.19%
6.28%
3.46%
12.41%
13.68%
EPS
0.00
0.78
-100.00%
0.84
1.40
-40.00%
1.45
0.59
145.76%
19.62
17.55
11.79%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Net Sales
445.10
364.91
332.62
301.36
278.36
Net Sales Growth
21.98%
9.71%
10.37%
8.26%
 
Cost Of Goods Sold
201.50
-90.00
-8.90
17.29
8.55
Gross Profit
243.60
454.90
341.52
284.07
269.82
GP Margin
54.73%
124.66%
102.68%
94.26%
96.93%
Total Expenditure
392.67
314.95
282.67
252.38
241.14
Power & Fuel Cost
-
1.01
1.13
1.39
1.07
% Of Sales
-
0.28%
0.34%
0.46%
0.38%
Employee Cost
-
31.83
27.58
23.32
24.78
% Of Sales
-
8.72%
8.29%
7.74%
8.90%
Manufacturing Exp.
-
232.19
138.30
110.61
127.95
% Of Sales
-
63.63%
41.58%
36.70%
45.97%
General & Admin Exp.
-
23.44
21.74
18.30
18.00
% Of Sales
-
6.42%
6.54%
6.07%
6.47%
Selling & Distn. Exp.
-
112.19
101.16
80.19
58.90
% Of Sales
-
30.74%
30.41%
26.61%
21.16%
Miscellaneous Exp.
-
4.28
1.65
1.29
1.89
% Of Sales
-
1.17%
0.50%
0.43%
0.68%
EBITDA
52.43
49.96
49.95
48.98
37.22
EBITDA Margin
11.78%
13.69%
15.02%
16.25%
13.37%
Other Income
7.82
4.55
0.63
0.55
1.85
Interest
15.99
10.65
9.20
10.36
10.64
Depreciation
3.98
3.82
3.26
3.01
3.08
PBT
44.24
40.04
38.12
36.16
25.35
Tax
4.67
1.98
1.95
1.15
3.95
Tax Rate
10.56%
4.88%
4.69%
3.18%
-6.23%
PAT
39.57
38.60
39.62
35.01
-67.39
PAT before Minority Interest
39.57
38.60
39.62
35.01
-67.39
Minority Interest
0.00
0.00
0.00
0.00
0.00
PAT Margin
8.89%
10.58%
11.91%
11.62%
-24.21%
PAT Growth
3.99%
-2.57%
13.17%
-
 
EPS
20.83
20.32
20.85
18.43
-35.47

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Shareholder's Funds
644.39
609.92
573.17
541.93
Share Capital
19.00
19.00
19.00
19.00
Total Reserves
625.38
590.91
554.17
522.92
Non-Current Liabilities
16.52
7.87
3.19
3.28
Secured Loans
1.61
2.83
0.40
0.66
Unsecured Loans
11.37
2.04
0.00
0.00
Long Term Provisions
3.54
3.00
2.79
2.61
Current Liabilities
365.30
262.45
216.43
194.29
Trade Payables
79.48
43.30
27.74
42.78
Other Current Liabilities
176.44
113.19
83.75
57.95
Short Term Borrowings
108.14
104.13
104.08
91.58
Short Term Provisions
1.24
1.83
0.87
1.97
Total Liabilities
1,026.21
880.24
792.79
739.50
Net Block
250.38
249.46
244.38
244.89
Gross Block
278.94
274.21
269.63
267.30
Accumulated Depreciation
28.56
24.75
25.25
22.41
Non Current Assets
336.20
308.57
272.97
271.72
Capital Work in Progress
0.00
0.00
0.00
0.00
Non Current Investment
5.78
6.05
5.05
5.05
Long Term Loans & Adv.
80.04
53.06
23.54
21.79
Other Non Current Assets
0.00
0.00
0.00
0.00
Current Assets
690.01
571.66
519.83
467.77
Current Investments
0.00
0.00
0.00
0.00
Inventories
338.02
230.31
207.85
220.34
Sundry Debtors
88.90
94.31
97.31
85.55
Cash & Bank
88.90
77.41
38.00
4.18
Other Current Assets
174.19
0.46
0.37
0.39
Short Term Loans & Adv.
172.17
169.17
176.30
157.30
Net Current Assets
324.71
309.22
303.40
273.48
Total Assets
1,026.21
880.23
792.80
739.49

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Cash From Operating Activity
17.58
74.59
38.37
17.05
PBT
40.58
41.56
36.16
-63.43
Adjustment
13.03
10.27
12.94
102.29
Changes in Working Capital
-34.95
23.09
-9.81
-18.93
Cash after chg. in Working capital
18.67
74.93
39.29
19.93
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-1.08
-0.34
-0.92
-2.88
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-3.96
-27.40
-2.88
-19.85
Net Fixed Assets
-4.56
-4.57
-2.33
Net Investments
0.01
-1.00
0.00
Others
0.59
-21.83
-0.55
Cash from Financing Activity
-2.13
-7.78
-1.67
-22.23
Net Cash Inflow / Outflow
11.49
39.41
33.81
-25.04
Opening Cash & Equivalents
77.41
38.00
4.18
29.22
Closing Cash & Equivalent
88.90
77.41
38.00
4.18

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 13
Mar 12
Book Value (Rs.)
339.08
320.94
301.61
285.16
35.91
28.57
ROA
4.05%
4.74%
4.57%
-15.03%
8.50%
7.73%
ROE
6.15%
6.70%
6.28%
-22.48%
22.76%
20.12%
ROCE
6.89%
7.26%
7.09%
-14.84%
23.88%
19.09%
Fixed Asset Turnover
1.32
1.22
1.12
1.62
2.08
2.22
Receivable days
91.63
105.14
110.74
69.85
44.32
36.68
Inventory Days
284.23
240.40
259.30
195.06
189.43
193.69
Payable days
-249.00
-1457.17
744.29
1503.38
67.06
55.99
Cash Conversion Cycle
624.86
1802.71
-374.25
-1238.47
166.69
174.38
Total Debt/Equity
0.19
0.18
0.18
0.17
0.33
0.25
Interest Cover
4.81
5.52
4.49
-4.96
4.35
6.02

News Update:


  • Nath Bio-Genes - Quarterly Results
    5th May 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.